Get Ready for More Vaccine Mandates – Experimental Pfizer COVID-19 Jab Expected to Gain Full FDA Approval Monday

We all knew this day was imminent.

On Friday, the announcement came that one of the experimental COVID-19 jabs would gain full approval by the FDA.

The Pfizer mRNA shot is the chosen one for the FDA stamp of approval.

From a legal standpoint, this is going to embolden more experimental COVID-19 vaccine mandates across the board.

In the public and private sectors.

And make no mistake, I will still refer to this as an experimental shot.

Just because the corrupt FDA gives them full approval, that doesn’t change the fact they haven’t gone through normal safety trials.

We’re still witnessing the aftermath of the real safety trials in the hundreds of millions who lined up for the experimental jabs this year.

Full FDA approval doesn’t change that.

But fighting against them now will be more difficult for many people who choose not to be a Big Pharma lab rat.

Many Americans will get forced from their jobs or banned from in-person educational institutes without receiving the experimental COVID-19 jab.

That’s why more people need to join the resistance against these tyrannical vaccine mandates.

Because this won’t go away until enough people say no.

Here’s the latest:

BREAKING: FDA is aiming to give full approval for the Pfizer #covid19 vaccine on Monday.

This will change everything and accelerate vaccination efforts, as many more businesses, colleges & schools will implement vaccine mandates. @noahweiland @SharonLNYThttps://t.co/2XltFGLXyc

— Leana Wen, M.D. (@DrLeanaWen) August 20, 2021

The FDA could grant the Pfizer-BioNTech Covid-19 vaccine full approval on Monday, The New York Times reported late Friday. https://t.co/JHL2IQxBFA

— NBC Bay Area (@nbcbayarea) August 21, 2021

Great news that FDA will grant full licensure to the Pfizer #COVID19 vaccine as early as this Monday. This is an important step that will assist vaccination efforts. https://t.co/yFXX2jJybs

— Tom Sandora (@tomsandora) August 20, 2021

The FDA had recently set a deadline of Labor Day to give the vaccine approval. https://t.co/ouUzCxsExV

— 13 Action News (@13abc) August 21, 2021

Full approval for Pfizer Covid vaccine expected from FDA on Monday https://t.co/CViRYZLFoU

— Wilson (@WilsonsWorld) August 20, 2021

Plus- the Pfizer vaccine likely will garner full FDA approval on Monday. No excuses left, folks!#GetVaccinatedASAP https://t.co/PtmBsWUvuC

— Carter County TN Democrats (@PartyCarter) August 21, 2021

GAME CHANGER: Full FDA approval of PFIZER as early as Monday…Will others follow? https://t.co/j7biDKFDCF

— End Time Headlines (@EndTimeHeadline) August 21, 2021

CNBC reported:

The Food and Drug Administration is working to approve the Pfizer-BioNTech Covid-19 vaccine on Monday, The New York Times reported, citing sources.

The review process could move past that date, the Times said, as paperwork and negotiations with the company continue.

The move would make it the first Covid vaccine to go from emergency use authorization to full FDA approval.

The FDA declined to comment on the Times report to CNBC.

White House chief medical advisor Dr. Anthony Fauci told the Associated Press on Aug. 8 that he hoped vaccines would start receiving full approval “within the month of August,” adding that full approval would lead more companies and schools to mandate vaccines.

U.S. companies have tightened vaccine rules for employees as Covid cases have spiked across the country in recent weeks, and some cited full approval from the FDA as part of the decision-making process.

Full approval could also help persuade people who are hesitant about getting vaccinated until the FDA fully signs off on the shot.

More than 203 million doses of the Pfizer-BioNTech vaccine have been administered nationwide, fully immunizing more than 91 million people in the U.S., according to CDC data as of Friday.

Pfizer and BioNTech initially began the process of applying for their biologics license for the two-dose vaccine in May after receiving emergency use authorization from the FDA in December. The FDA sets a six-month target for approving high-priority drugs.

Reuters had this update:

The approval could boost the vaccination campaign by convincing more unvaccinated Americans that Pfizer’s shot is safe and effective and also make local officials more comfortable in implementing vaccine mandates.

The U.S. military is expected to require that service members get vaccinated soon after Pfizer’s shot is authorized and other major U.S. employers could follow suit.

NATIONAL POLL: Should Fauci Be Prosecuted For LYING To Congress?

Vaccine hesitancy has been a major hurdle to the White House’s goal of getting all eligible Americans vaccinated against the coronavirus.

Only around 60% of adults aged 18 and over have been fully vaccinated even as the new Delta variant of COVID-19 has contributed to a surge in cases.

Full approval of Pfizer’s shot would also make it easier for physicians to prescribe a third booster shot to people who could benefit from an additional dose.

The FDA has authorized Pfizer’s shot as a booster for people with weakened immune systems, but the White House plans to offer them much more widely in the coming months.

The White House earlier this week said it plans to give out 100 million booster shots, many supplied by Pfizer, to at-risk Americans, including anyone whose initial inoculation is more than 8 months old, starting in September.

Some experts, including at the World Health Organization say there is not yet enough data be certain boosters are needed.